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Abstract
Background: To determine the anthropometric indices that would predict type 2 diabetes (T2D) and delineate
their optimal cut-points.
Methods: In a cohort study, 7017 Iranian adults, aged 20–60 years, free of T2D at baseline were investigated. Using
Cox proportional hazard models, hazard ratios (HRs) for incident T2D per 1 SD change in body mass index (BMI),
waist circumference (WC), waist to height ratio (WHtR), waist to hip ratio (WHR), and hip circumference (HC) were
calculated. The area under the receiver operating characteristics (ROC) curves (AUC) was calculated to compare the
discriminative power of anthropometric variables for incident T2D. Cut-points of each index were estimated by the
maximum value of Youden’s index and fixing the sensitivity at 75%. Using the derived cut-points, joint effects of
BMI and other obesity indices on T2D hazard were assessed.
Results: During a median follow-up of 12 years, 354 men, and 490 women developed T2D. In both sexes, 1 SD
increase in anthropometric variables showed significant association with incident T2D, except for HC in multivariate
adjusted model in men. In both sexes, WHtR had the highest discriminatory power while HC had the lowest. The derived
cut-points for BMI, WC, WHtR, WHR, and HC were 25.56 kg/m2, 89 cm, 0.52, 0.91, and 96 cm in men and 27.12 kg/m2,
87 cm, 0.56, 0.83, and 103 cm in women, respectively. Assessing joint effects of BMI and each of the obesity
measures in the prediction of incident T2D showed that among both sexes, combined high values of obesity
indices increase the specificity for the price of reduced sensitivity and positive predictive value.
Conclusions: Our derived cut-points differ between both sexes and are different from other ethnicities.
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Background
Diabetes is the most prevalent metabolic disorder in the
world [1]. It is a coronary heart disease equivalent [2–4]
and had a substantial global burden with 680
disability-adjusted life years per 100,000 people in 2010
[1]. By 2035 the prevalence of type 2 diabetes (T2D) will
increase by 55% worldwide with an alarming pace in
developing countries such as those in the Middle East
and North Africa region (approximately 96.2% increase
in prevalence in 20 years) [5].
One of the major modifiable risk factors of T2D is
obesity [6–10]. Despite clear evidence linking obesity to
various health outcomes including cardiovascular
diseases (CVD), obesity has been a puzzling condition
for clinicians because it is quite heterogeneous [11] and
the existing evidence regarding the suitable anthropo-
metric index to be used as a screening test in each sex is
controversial. On the one hand, the literature supports
the application of central obesity, such as waist to height
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ratio (WHtR) over general obesity indicators in assessing
T2D risk [12, 13]. On the other hand, there are studies
that use body mass index (BMI) as their main obesity
index in predicting T2D [14–16]. Several studies have
been conducted to obtain the optimum cut-points of an-
thropometric indices [17–22]. However, these studies were
mainly conducted in Asians, European and American
Caucasians. Understandably, the results are not necessar-
ily generalizable to other ethnicities [23]. Therefore,
WHO has emphasized the need for prospective studies to
derive and validate ethnic-specific cut-points of body fat
composition indices to predict CVD and T2D [24].
Located in the Middle East, Iran suffers from high inci-
dence and prevalence of T2D [10, 25]. Yet, data regarding
appropriate anthropometric cut-points in the Iranian
population using prospective studies is limited [26].
In the current study, we decided to determine the
sex-specific independent and combined risk of different
anthropometric indices in the prediction of T2D in the
cohort of Tehran Lipid and Glucose Study (TLGS) with
over 12 years of follow-up; furthermore, we compared
the discriminatory power of adiposity measures and de-
lineated their optimal cut-points in this population.
Methods
Study design and sample
The TLGS, an ongoing prospective population-based
study being performed on a representative sample of the
Tehran population, aims to determine the prevalence
and incidence of non-communicable diseases and their
risk factors. Detailed descriptions of the TLGS have
been reported elsewhere [27]. In brief, one baseline
(1999–2001) and 4 follow-up examinations at triennial
intervals have been carried out until January 2015.
Those who had cancer, end-stage renal disease or
cirrhosis were excluded from the TLGS at the base-
line examination [28]. For the current study, 10,727
participants, aged 20–60 years [8569 people from the
baseline examination (1999–2001) and 2158 new partici-
pants recruited from the second phase (2001–2005)], were
selected. Subjects with prevalent T2D at their baseline
examination [N = 806, excluding those with known T2D
using anti-diabetic medications (N = 276), 32 participants
had isolated high fasting plasma glucose (FPG), 95 sub-
jects had high FPG levels while their 2 h-post-challenge
plasma glucose (2 h-PCPG) was missing, 202 participants
had isolated high 2 h-PCPG and 201 had combined high
FPG and high 2 h-PCPG], no data on baseline variables
(N = 1342) or not any follow-up data (N = 1562) were
excluded; leaving 7017 participants (2988 men, 4029
women) to include in the analyses as respondents
(response rate = 7017/(10,727–806) × 100 = 70.7%). Fur-
thermore, to compare the discriminatory power of
anthropometric indices and to delineate their optimal
cut-points for the prediction of T2D in each sex, the ana-
lyses were performed only among those who participated
in the last follow-up phase and those with incident T2D
during the follow-ups (N = 5738, 2419 men, 3319 women)
(Additional file 1).
Clinical and laboratory measurements
Using a pretested questionnaire, a trained interviewer
collected information regarding demographic data, drug
history and family history of T2D. Weight was mea-
sured, with subjects minimally clothed without shoes,
using digital scales (Seca 707: range 0–150 kg) and
recorded to the nearest 1 kg. Using a tape meter, height
was measured in a standing position without shoes,
while shoulders were in normal alignment; waist circum-
ference (WC) was measured at the umbilical level and
that of the hip (HC) at the widest girth of the hip over
light clothing, without any pressure to the body surface.
Measurements were recorded to the nearest 1 cm. Body
mass index (BMI) was calculated as weight (Kg) divided
by height squared (m2). Waist to hip (WHR) and waist
to height ratios (WHtR) were calculated as WC (cm)
divided by HC (cm) and height (cm), respectively. Wrist
circumference was measured with the anterior wrist
surface facing up. The superior border of the tape meter
was placed just distal to the prominences of the radial
and ulnar bones, without any tape pressure over it;
values were recorded to the nearest 0.1 cm.
After a 15-min rest in the sitting position, two
measurements of systolic and diastolic blood pressure
(SBP and DBP) were taken on the right arm, using a
standardized mercury sphygmomanometer (calibrated by
the Iranian Institute of Standards and Industrial
Researches); the mean of the two measurements was
considered as the participant’s blood pressure.
A blood sample was taken between 7:00 and 9:00 AM
from all study participants, after 12 to 14 h of overnight
fasting. All blood analyses were carried out at the TLGS
research laboratory on the day of the blood collection.
For all non-pharmacologically treated diabetic partici-
pants aged ≥20 years, an oral glucose tolerance test with
82.5 g of glucose monohydrate solution [equivalent to
75 g of anhydrous glucose; Cerestar EP, Spain] was
performed; a second blood sample was obtained 2 h
after glucose ingestion. Fasting plasma glucose (FPG)
and 2 h-post-challenge plasma glucose (2 h-PCPG) were
measured using an enzymatic colorimetric method with
glucose oxidase; inter- and intra-assay coefficients of
variation at baseline and follow-up phases were both less
than 2.3%.
High-density lipoprotein cholesterol (HDL-C) was
measured after precipitation of the apolipoprotein B
containing lipoproteins with phosphotungstic acid. Tri-
glycerides (TG) were assayed using glycerol phosphate
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oxidase. Both inter- and intra-assay coefficients of
variation were less than 3 and 2.1% for HDL-C and TG,
respectively. Analyses were performed using Pars Azmon
kits (Pars Azmon Inc., Tehran, Iran) and a Selectra 2
auto-analyzer (Vital Scientific, Spankeren, Netherlands).
Triglyceride to high-density lipoprotein cholesterol ratio
(TG/HDL-C) was calculated by dividing TG to HDL-C.
All samples were analyzed when internal quality control
met the acceptance criteria.
Definition of terms
Subjects who reported a parent or sibling with diabetes
were considered as having a positive family history of
T2D. Education level was classified in 3 categories: i)
those who had studied less than 6 years, ii) those who
had studied for 6–12 years, and iii) those with more than
12 years of education. In accordance with the definition
provided by the American Diabetes Association, [29]
participants were considered to have T2D if they met at
least one of these criteria: FPG ≥7.0 mmol/L, or
2 h-PCPG ≥11.1 mmol/L or taking anti-diabetic medica-
tion. In addition, participants with missing data on
2 h-PCPG at follow-up who simultaneously had FPG
levels< 5.05 mmol/L were considered free of T2D [30].
Statistical methods
All statistical analyses were stratified by sex. Continuous
variables were described as mean (standard deviation
(SD)) or median (interquartile range (IQR)), and categor-
ical variables were summarized as frequency (percent-
age). Baseline characteristics of men and women, as well
as respondent and non-respondent groups, were com-
pared using independent T-test, Mann-Whitney U test,
and Chi-square test whichever indicated. The event date
for diabetes cases was described as the middle-time be-
tween the date of follow-up visit at which diabetes was
detected for the first time, and the most recent
follow-up visit preceding the diagnosis; the follow-up
time was considered as the difference between the calcu-
lated mid-time date and the date at which the subjects
entered the study. For the censored subjects, the survival
time was the interval between their first and last obser-
vation dates.
Cox proportional hazard models with age as the time
scale [31] were used to estimate the hazard ratios (HRs)
with 95% confidence intervals (95% CIs) for incident
T2D per 1 SD increase in anthropometric indices in uni-
variate (without adjustment for any other variables) and
adjusted multivariable models. In model 1, the hazard
ratio of interest was adjusted for education, family his-
tory of T2D, SBP, FPG, and TG/HDL-C. In model 2, the
hazard ratio of interest was adjusted for variables in-
cluded in model 1 plus wrist circumference as it has
been shown to be a significant predictor of T2D in the
TLGS adult population [32].
The proportional hazards assumption in the Cox
models was assessed both graphically and using the
Schoenfeld residual test. All proportionality assumptions
were met. Collinearity was checked by estimating the
first order correlation coefficients between variables used
in each model as well as using correlation matrix of co-
efficients in the multivariable adjusted cox model [33].
There was no pair of variables with correlation coeffi-
cient of 0.80 or more in models. Receiver operating
characteristics (ROC) curves were plotted to compare
the discriminative power of different anthropometric in-
dices for the prediction of incident T2D. The equality of
the area under the ROC curves (AUCs) of different an-
thropometric indices was tested using the Stata command
‘roccomp’ [34]. Using the “R optimal cut-point package”,
[35] cut-points for each variable were estimated by i) the
maximum value of Youden’s index i.e., sensitivity+specifi-
city-1, [36] ii) setting the sensitivity at 75%.
To examine the joint effects of BMI-WC, BMI-WHtR,
BMI-WHR, and BMI-HC on the hazard of T2D in each
sex, combined variables were created. To compare 4 cat-
egories, considering those with normal BMI-WC,
BMI-WHtR, BMI-WHR, and BMI-HC as reference
groups, using our cut-points derived from the fixed sen-
sitivity at 75%, Cox proportional hazard models with age
as the time scale were used in univariate and adjusted
multivariable models. Model 1 was adjusted for educa-
tion, family history of T2D, SBP, FPG, and TG/HDL-C.
Model 2 was adjusted for variables included in model 1
and wrist circumference. All analyses were done using
Stata (version 12.0) and R (version 3.4.3).
Results
The study population consisted of 2988 men and 4029
women with the mean (SD) ages of 37.8 (10.2) and 37.3
(10.4) years, respectively. Baseline characteristics of re-
spondents and non-respondents (eligible participants
whose baseline or follow-up data were missing) are
shown in Additional file 2. The only significant differ-
ence between these two groups was that respondents
were 4 years older than their non-respondent counter-
parts. All other variables were generally the same in both
groups. Table 1 depicts baseline characteristics of re-
spondent men and women. Men were older and had
higher levels of education, wrist circumference, SBP,
FPG and log TG/HDL-C. Regarding anthropometric in-
dices, men had higher WC and WHR, whereas, BMI,
HC, and WHtR were higher in women. Frequency of
baseline consumption of angiotensin-converting enzyme
inhibitors (ACEIs), diuretics, corticosteroids and
lipid-lowering drugs in men were 0.6, 0.5, 1.5, and 1.4%,
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respectively; the corresponding values for women were
0.7, 1.9, 1.9, and 2%, respectively.
During a median follow-up (IQR) of 11.9 (4.6)
years, 354 new cases of T2D in men and 490 ones in
women were detected resulting in an annual crude
incidence rate (95% CI) of 10.9 (9.8–12.1) and 11.1
(10.1–12.1) diabetes per 1000 person-years of
follow-up in men and women, respectively. Table 2
illustrates sex-specific adjusted HRs (95% CIs) for
incident T2D per 1 SD increase in anthropometric
indices using the univariate and multivariable-adjusted
Cox proportional hazard models. In men, in line with
the univariate model, model 1 indicated statistically
significant associations between all anthropometric
measures and T2D incidence with HRs ranging from
1.25 for HC to 1.37 for BMI. Considering the wrist
circumference as a surrogate of body frame in model 2,
the hazardous association of all the obesity measures for
development of T2D was shown except for HC (HR 0.92,
95% CI: 0.80–1.06). In women, similar to the univariate
model, model 1 indicated statistically significant hazard-
ous associations between all anthropometrics and incident
T2D, with HRs ranging from 1.24 for HC to 1.51 for
WHtR. However, after adjusting for wrist circumference
in model 2, all the HRs decreased but still remained statis-
tically significant.
Fig. 1 shows sex-specific ROC curves and the AUCs
(95% CIs) for different anthropometric indices. In both
sexes, WHtR had the highest AUC (0.69, 95% CI:
0.67–0.72, in men and 0.75, 95% CI: 0.73–0.78, in
women), whereas HC had the lowest values (0.62, 95%
CI: 0.59–0.65, in men and 0.66, 95% CI: 0.64–0.69, in
women).
Table 3 shows the sex-specific cut-points of different
anthropometric indices for the prediction of incident
T2D. In men, fixing sensitivity at 75%, the calculated
cut-points for BMI, WC, WHtR, WHR, and HC were
25.56 kg/m2, 89 cm, 0.52, 0.91, and 96 cm while the
corresponding values for the Youden’s index were
26.49 kg/m2, 87 cm, 0.54, 0.92, and 96 cm, respectively.
In women, fixing sensitivity at 75%, the calculated
cut-points for BMI, WC, WHtR, WHR, and HC were
27.12 kg/m2, 87 cm, 0.56, 0.83, and 103 cm while the
corresponding values for the Youden’s index were
29.27 kg/m2, 91 cm, 0.56, 0.83, and 106 cm, respectively.
Table 4, illustrates the joint effects of BMI and other
obesity measures on the hazard of developing T2D,
based on the cut-points derived from the fixed sensitivity
at 75%, in men. As shown in the table, high BMI,
whether alone or combined with high other obesity
measures, had a significant risk for incident T2D both in
univariate and multivariate models (except for high
BMI-low HC). Among men population with normal
BMI, only the presence of high WHR showed significant
risk for incident T2D in the fully adjusted analysis (HR
1.55, 95% CI: 1.01–2.38).
Table 1 Baseline characteristicsa of respondents, Tehran Lipid and Glucose Study (1999–2015)
Men (N = 2988) Women (N = 4029) Difference (CI)
Age (years) 37.8 (10.2) 37.3 (10.4) 0.5 (0.0;0.1)
Family History of T2D; No. (%) 790 (26.4) 1115 (27.7) −1.2% (−3.3;0.8)
Education Level; No. (%)
< 6 years 471 (15.8) 1127 (28.0) −12.2% (− 14.1; − 10.3)
6–12 years 1888 (63.2) 2402 (59.6) 3.6% (1.2;5.9)
> 12 years 629 (21.1) 500 (12.4) 8.6% (7.8; 10.4)
Wrist Circumference (cm) 17.6 (1.0) 15.9 (1.0) 1.7 (1.6; 1.7)
WC (cm) 88.4 (11.1) 86.0 (12.3) 2.4 (1.8;2.9)
Height (cm) 171.1 (6.6) 157.4 (5.8) 13.7 (13.4;14.0)
WHtR 0.51 (0.06) 0.54 (0.08) −0.03 (−0.033; −0.026)
BMI (kg/m2) 25.7 (4.1) 27.2 (4.9) −1.5 (−1.7; −1.3)
HC(cm) 96.8 (7.2) 103.9 (9.5) −7.1 (−7.6; −6.7)
WHR 0.91 (0.06) 0.82 (0.07) 0.08 (0.08;0.09)
SBP (mmHg) 116.0(14.1) 113.5 (15.6) 2.5 (1.8;3.3)
DBP (mmHg) 76.6 (10.3) 75.8 (10.3) 0.8 (0.3;1.3)
FPG (mmol/L) 5.00 (0.50) 4.91 (0.51) 0.09 (0.07;1.2)
Log TG/HDL-C 0.60 (0.71) 0.26 (0.69) 0.37 (0.34;0.40)
aFor continuous variables, values are presented as mean (SD) and difference (95% CI) was estimated using linear regression models. Categorical variables are
presented as frequency (percentage) and difference (95% CI) was estimated by logistic regression
CI confidence interval, T2D type 2 diabetes mellitus, WC waist circumference, WHtR waist to height ratio, BMI body mass index, HC hip circumference, WHR waist
to hip ratio, SBP systolic blood pressure, DBP diastolic blood pressure, FPG fasting plasma glucose, TG/HDL-C triglyceride to high density lipoprotein cholesterol ratio
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Table 5, illustrates the joint effects of BMI and other
obesity measures on the hazard of incident T2D, based on
the derived cut-points from the fixed sensitivity at 75%, in
women. Analyses revealed that high obesity measures
whether alone or in combination with each other were
generally associated with higher risk of developing T2D
compared to the reference group. However, there were
two exceptions: i) in those with high BMI-normal WHtR
whose increased risk was not statistically significant in the
multivariate models and ii) in those with normal
BMI-high HC whose HRs were not significantly increased
neither in univariate nor in multivariate models.
Table 6 depicts the sensitivity, specificity and positive
predictive value (PPV) of combinations of high BMI-
high WC, high BMI- high WHtR, high BMI- high WHR,
and high BMI- high HC using the derived cut-points by
fixing sensitivity at 75% in men and women. As shown
in the table, all the sensitivities fell to values under 70%,
whereas the reported specificities were increased com-
pared to the values displayed in Table 3. The overall
effect of combining high measures together was a mild
reduction in the PPVs.
Discussion
Investigated in a large Iranian cohort study with 12 years
of follow-up, all anthropometric variables showed sig-
nificant association with incident T2D after adjustment
for a wide set of covariates including a surrogate of body
frame (wrist circumference) in both sexes, excluding hip
circumference in men. Assessing their discriminatory
power, in both sexes, WHtR performed the best, whereas
HC showed the lowest prediction power. The derived
cut-points of anthropometric indices for predicting the
development of T2D in our population were generally
different for men and women. Investigating the accuracy
of combination of BMI and other obesity measures in
predicting development of T2D revealed that in both
sexes, the combined high values of general and central
obesity indices increase the specificity for the price of
reduced sensitivity and PPV.
In literature, there is almost unanimous agreement on
the association of all general and central obesity measures
with incident T2D in both sexes [15, 17, 19, 20, 22, 37–39].
However, controversy remains as to which index can pre-
dict incident T2D, independent of other obesity variables.
While several studies suggest central obesity measures as
the main obesity indices predicting T2D in men, [38–40].
there are investigations highlighting the role of general
obesity as the optimal index [14, 15]. In line with other
studies, we found that in both men and women, all an-
thropometric indices are almost similarly associated with
T2D. Moreover, in our study, while wrist circumference
acted as a positive risk factor for developing T2D in
women, in men it showed a negative association. Similarly,
Jahangiri et al. showed the positive association between
wrist circumference and incident T2D in women [32].
With regards to HC, similar to other studies, [41–43]
we showed the hazardous association of larger HC with
development of T2D in both sexes in the multivariate
analysis adjusted for traditional T2D risk factors; the
Table 2 Associations between anthropometric indices and incident type 2 diabetes, Tehran Lipid and Glucose Study (1999–2015)
Univariate model Model 1b Model 2c
HRa (95% CI) P-value HR (95% CI) P-value HR (95% CI) P-value
Men
BMI (kg/m2) 1.69 (1.54–1.85) < 0.001 1.37 (1.24–1.51) < 0.001 1.48 (1.31–1.68) < 0.001
WC (cm) 1.69 (1.52–1.87) < 0.001 1.35 (1.21–1.50) < 0.001 1.43 (1.26–1.64) < 0.001
WHtR 1.66 (1.51–1.83) < 0.001 1.36 (1.23–1.50) < 0.001 1.39 (1.24–1.55) < 0.001
WHR 1.52 (1.38–1.67) < 0.001 1.27 (1.14–1.41) < 0.001 1.26 (1.13–1.40) < 0.001
HC (cm) 1.52 (1.38–1.67) < 0.001 1.25(1.14–1.37) < 0.001 0.92(0.80–1.06) 0.304
Women
BMI (kg/m2) 1.74 (1.60–1.89) < 0.001 1.42 (1.30–1.56) < 0.001 1.41 (1.27–1.57) < 0.001
WC (cm) 1.90 (1.74–2.08) < 0.001 1.48 (1.34–1.64) < 0.001 1.46 (1.30–1.64) < 0.001
WHtR 1.93 (1.76–2.12) < 0.001 1.51 (1.37–1.68) < 0.001 1.47 (1.32–1.64) < 0.001
WHR 1.57 (1.44–1.71) < 0.001 1.30 (1.19–1.42) < 0.001 1.27 (1.16–1.39) < 0.001
HC (cm) 1.46 (1.35–1.58) < 0.001 1.24(1.14–1.35) < 0.001 1.11(1.00–1.24) 0.043
aPer 1 SD increase for each index (SD of WC = 11.13, BMI = 4.08, HC = 7.16, WHR = 0.06, WHtR = 0.06 in men and WC = 12.31, BMI = 4.90, HC = 9.51, WHR = 0.07,
WHtR = 0.08 in women)
bAdjusted for age (in time-scale manner), education level, family history of type 2 diabetes, systolic blood pressure, fasting plasma glucose, and triglyceride to
high-density lipoprotein cholesterol ratio
cAdjusted for model 1 variables and wrist circumference
HR hazard ratio, CI confidence interval, BMI body mass index, WC waist circumference, WHtR waist to height ratio, WHR waist to hip ratio, HC hip circumference
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association which reached to null after considering body
frame (wrist circumference) in men. Moreover, further
adjustment of HC for BMI, as suggested by many inves-
tigators, [44, 45] reversed this association only in women
(HR 0.77, 95% CI: 0.65–0.92 in women, HR 0.82 95% C:
0.66–1.02 in men). Obesity is linked to higher risk of
T2D [46]. However, there are studies which has reported
a better metabolic profile in individuals who had more
gluteofemoral mass for a given amount of abdominal fat
[47–49]. The possible explanation for such effect is that
HC is a presentation of several components namely the
bone, the gluteal muscles, and the gluteal subcutaneous
fat [50]. Each component plays its own role in the
process of developing T2D. Gluteal muscles are one of
the main sites of insulin receptors. Therefore, higher
gluteal muscle mass may be indicative reduced risk of
insulin resistance which is commonly followed by devel-
opment of T2D. The effect of gluteofemoral fat mass on
metabolism has been investigated in physiological
studies [51, 52]. A study by Manolopoulos et al [52]
proposed that the fat mass in the gluteofemoral region
traps the surfeit serum fatty acids which results in a low
serum lipid levels. Furthermore, authors suggested that
secreting adipokines leptin and adiponectin, the gluteo-
femoral fat mass might play a protective role in the
development of T2D. Finally, Kuk et al. showed that in
Fig. 1 Receiver operating characteristic (ROC) curves, area under the curves (AUCs) and 95% confidence intervals for different anthropometrics by
gender. P-values for AUCs comparison in men: BMI-WC: 0.51; BMI-WHR: 0.84; BMI-WHtR: 0.11; BMI-HC: < 0.001; WC-WHR: 0.80; WC-WHtR: 0.002;
WC-HC: < 0.001; WHtR-HC: < 0.001; WHR-WHtR: 0.10; WHR-HC: < 0.001. P-values for AUCs comparison in women: BMI-WC: 0.002; BMI-WHR: 0.68;
BMI-WHtR: < 0.001; BMI-HC: < 0.001; WC-WHR: 0.001; WC-WHtR: 0.004; WC-HC: < 0.001; WHtR-HC: < 0.001; WHR-WHtR: < 0.001; WHR-HC: 0.003.
WHtR, waist to height ratio; WC, waist circumference; WHR, waist to hip ratio; BMI, body mass index
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both sexes, for a given WC, higher HC is associated with
higher gluteofemoral and abdominal subcutaneous fat
mass and skeletal muscle while being associated with
lower visceral fat mass [53].
Regarding the discriminatory power of anthropometric
measures, in both sexes, among all the investigated an-
thropometric measures, WHtR had the highest prediction
power, whereas HC had the lowest. Results of the current
study are in line with several cohort studies [17, 22]. Previ-
ously, in short-term follow-up, we showed the superiority
of WHtR to BMI in the prediction of T2D in both genders
[54, 55]. The differences between our short versus
long-term follow up studies might be due to different
follow-up times, statistical approaches and covariates. Re-
cently, a systematic review and meta-analysis by Ashwell
et al [13] revealed a stronger association of WHtR with
T2D rather than BMI in both genders.
In the current study, we looked for cut-points of
different anthropometric measures using Youden’s
index, which gives equal weight to both the sensitivity
and specificity. Clinically, however, these may not be
the appropriate cut-points since sensitivity versus
specificity must be weighed against the seriousness of
the disease, and the test under evaluation (whether it
Table 3 Sex-specific diagnostic test performance of the anthropometric indices for incident type 2 diabetes, TLGS study
Cut-point No. of subjects above cut-point No. of Incident T2D Sensitivity (%) Specificity (%) PPV (%)
Men (N = 2419)
BMI (kg/m2)
Youden’s index 26.49 1043 243 67.7 61.4 23.3
Sensitivity = 75% 25.56 1258 269 74.9 52.0 21.4
WC (cm)
Youden’s index 87.00 1415 292 81.3 45.5 20.6
Sensitivity = 75% 89.00 1254 265 73.8 52.0 21.1
WHtR
Youden’s index 0.54 940 224 62.7 65.0 23.8
Sensitivity = 75% 0.52 1229 262 74.9 51.4 21.3
WHR
Youden’s index 0.92 1122 246 71.9 55.5 21.9
Sensitivity = 75% 0.91 1247 267 75.2 50.3 21.4
HC (cm)
Youden’s index 96.00 1418 268 74.6 44.2 18.9
Sensitivity = 75% 96.00 1418 268 74.6 44.2 18.9
Women (N = 3319)
BMI (kg/m2)
Youden’s index 29.27 1080 300 60.4 72.4 27.8
Sensitivity = 75% 27.12 1619 373 75.0 55.8 23.0
WC (cm)
Youden’s index 91.00 1166 331 66.6 70.4 28.4
Sensitivity = 75% 87.00 1557 376 75.6 58.2 24.1
WHtR
Youden’s index 0.56 1365 366 73.6 64.8 26.8
Sensitivity = 75% 0.56 1414 373 75.0 63.1 26.4
WHR
Youden’s index 0.83 1502 358 73.0 59.1 23.8
Sensitivity = 75% 0.83 1589 371 75.0 56.7 23.3
HC (cm)
Youden’s index 106.00 1338 302 60.8 63.3 22.6
Sensitivity = 75% 103.00 1833 367 73.8 48.0 20.0
T2D type 2 diabetes mellitus, PPV positive predictive value, BMI body mass index, WC waist circumference, WHtR waist to height ratio, WHR waist to hip ratio,
HC hip circumference
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is a simple measurement or an invasive test and its
cost). Hence, considering the coronary heart disease
equivalency of T2D among Iranian population, [4] in
line with the Inter99 Study, [16] we decided not to
miss more than 25% of at-risk participants and fixed
the sensitivity of all the anthropometric cut-points at
about 75%; the cut-points resulted in specificities
above 50% in all of the anthropometric measures ex-
cept HC. Accordingly, for BMI, we recommend using
25.56 kg/m2 as a predictive cut-point in men and
27.12 kg/m2 in women. Data of the national
non-communicable disease risk factors surveillance in
Iran suggested cut-points close to the current study
(24.8 kg/m2 in men and 26.3 kg/m2 in women) [56].
Assessing the accuracy of the ADA suggested cut-point
[29] of BMI ≥ 25 kg/m2 in our population, its sensitivity
and specificity were 89.2 and 37.5% in women and 78.8
and 46.7% in men, respectively which have noticeably
lower specificities compared to our suggested cut-points.
Our recommended cut-points for WC are 89 cm in men
and 87 cm in women. Studies in different populations sug-
gest different WC cut-points for predicting T2D which
sounds reasonable due to ethnic differences [23, 24].
IDF suggested to use WC ≥ 94 cm and ≥ 80 cm in
Middle-Eastern men and women, respectively [57].
Comparison between the false positive rates using our
derived cut-points versus the ones suggested by IDF
shows that our derived cut-point of 87 cm in women
performed better (0.42 versus 0.66, respectively), how-
ever, in men, IDF cut-points showed lower false posi-
tive rates (0.47 and 0.30, respectively). But it should
be considered that the sensitivity of WC cut-point
suggested by IDF decreased to 54.2%; the issue which
is not appropriate for screening T2D [16]. As a gen-
eral finding in our study, when fixing the sensitivity
at 75%, there was not a noticeable difference in speci-
ficity and PPV of the cut-points in men but in
women, WHtR suggested cut-point had a higher spe-
cificity and PPV compared to other indices. Focusing
on WHtR, we suggest the cut-point of 0.52 in men
and 0.56 in women, results that somewhat support
findings of a systematic review by Ashwell et al [13]
to “keep your waist to less than half your height”.
However, our derived cut-points showed a lower false
positive rate both in men (0.46 versus 0.58) and
women (0.38 versus 0.67).
Table 4 Joint-effects of BMI and other central obesity measures on the hazard of type 2 diabetes in men, TLGS study
Incident T2D /total participants Univariate model Model 1a Model 2b
(%) HR (95% CI) P Value HR (95% CI) P-value HR (95% CI) P-value
BMI (kg/m2)-WC(cm)
< 25.56- < 89 70/1302 (5.38) Reference – Reference – Reference –
≥ 25.56- < 89 24/191 (12.57) 2.23(1.40–3.56) 0.001 1.75(1.10–2.80) 0.018 1.83(1.14–2.95) 0.012
< 25.56-≥ 89 19/184 (10.33) 1.54(0.93–2.57) 0.093 1.04(0.62–1.74) 0.879 1.07(0.64–1.81) 0.778
≥ 25.56-≥ 89 241/1311 (18.38) 3.13(2.39–4.09) < 0.001 2.21(1.67–2.91) < 0.001 2.38(1.75–3.25) < 0.001
BMI (kg/m2)- WHtR
< 25.56- < 0.52 73/1311 (5.57) Reference – Reference – Reference –
≥ 25.56- < 0.52 24/202 (11.88) 2.09(1.32–3.32) 0.002 1.73(1.08–2.75) 0.020 1.81(1.13–2.92) 0.014
< 25.56-≥ 0.52 16/175 (9.14) 1.18(0.68–2.04) 0.549 0.80(0.46–1.40) 0.444 0.80(0.46–1.39) 0.437
≥ 25.56-≥ 0.52 241/1300 (18.54) 2.98(2.28–3.88) < 0.001 2.08(1.58–2.74) < 0.001 2.20(1.64–2.97) < 0.001
BMI (kg/m2)- WHR
< 25.56- < 0.91 48/1116 (4.3) Reference – Reference – Reference –
≥ 25.56- < 0.91 44/354 (12.43) 2.89(1.92–4.36) < 0.001 2.08(1.37–3.15) 0.001 2.20(1.43–3.38) < 0.001
< 25.56-≥ 0.91 41/370 (11.08) 2.05(1.34–3.13) 0.001 1.54(1.00–2.36) 0.047 1.55(1.01–2.38) 0.044
≥ 25.56-≥ 0.91 221/1148 (11.85) 3.87(2.82–5.31) < 0.001 2.70(1.95–3.74) < 0.001 2.88(2.03–4.08) < 0.001
BMI (kg/m2)- HC
< 25.56- < 96 68/1147 (5.93) Reference – Reference – Reference –
≥ 25.56- < 96 23/158 (14.56) 1.98(1.23–3.18) 0.005 1.35(0.83–2.19) 0.224 1.41(0.86–2.30) 0.164
< 25.56-≥ 96 21/339 (6.19) 1.03(0.63–1.69) 0.881 0.86(0.52–1.41) 0.564 0.92(0.55–1.51) 0.774
≥ 25.56-≥ 96 242/1344 (18.01) 2.92(2.23–3.83) < 0.001 2.15(1.63–2.84) < 0.001 2.40(1.75–3.30) < 0.001
aAdjusted for age (in time-scale manner), education level, family history of type 2 diabetes, systolic blood pressure, fasting plasma glucose, and triglyceride to
high-density lipoprotein cholesterol ratio
bAdjusted for model 1 variables and wrist circumference
HR hazard ratio, CI confidence interval, BMI body mass index, WC waist circumference, WHtR waist to height ratio, WHR waist to hip ratio, HC hip circumference
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Considering the limitation of the available data,
[19, 20, 58] the joint analyses in the current study
extend the understanding of the combined influence
of obesity measures on incident T2D. In line with
our study, Meisinger et al. showed that there are
differences in the sex-specific relevance of measures
of body fat distribution in predicting incident T2D
[19]. In women, our findings suggested that different
combinations of BMI-WC, BMI-WHtR, BMI-WHR,
and BMI-HC (except high BMI-low WHtR and low
BMI-high HC) were associated with high risk of
developing T2D. In men, we showed that high BMI either
in conjunction with high obesity indices or normal ones
(except for normal HC) had a significant association with
incidence of T2D in future, whereas those with normal
BMI but high WHtR, WC or HC did not show a sig-
nificant risk for the development of T2D. On the
other hand, some studies proposed that BMI, WC,
and WHR have very similar predictive powers for in-
cident T2D [19, 20]. This difference may be explained
by variation in methodological approaches and the sample
size. It should be kept in mind that although from a statis-
tical point of view some of the anthropometric measures
have a stronger association with T2D and can predict it
better, from a clinical perspective we cannot say that one
obesity measure overweighs the other. It would be rational
to ask physicians to refer those with higher than normal
Table 5 Joint-effects of BMI and other central obesity measures on the hazard of type 2 diabetes in women, TLGS study
Incident T2D /total participants Univariate model Model 1a Model 2b
(%) HR (95% CI) P value HR (95% CI) P-value HR (95% CI) P-value
BMI (kg/m2)-WC(cm)
< 27.12- < 87 77/1776(4.34) Reference – Reference – Reference –
≥ 27.12- < 87 44/389(11.31) 2.29(1.58–3.33) < 0.001 1.89(1.29–2.75) 0.001 1.79(1.22–2.61) 0.003
< 27.12-≥ 87 46/309(14.86) 2.66(1.83–3.87) < 0.001 2.05(1.41–2.97) < 0.001 1.99(1.36–2.89) < 0.001
≥ 27.12-≥ 87 323/1555(20.77) 3.76(2.89–4.89) < 0.001 2.30(1.75–3.02) < 0.001 2.06(1.53–2.77) < 0.001
BMI (kg/m2)- WHtR
< 27.12- < 0.56 81/1848(4.38) Reference – Reference – Reference –
≥ 27.12- < 0.56 42/463(9.07) 1.86(1.27–2.70) 0.001 1.45(0.99–2.11) 0.053 1.36(0.92–1.99) 0.113
< 27.12-≥ 0.56 42/237(17.72) 3.13(2.13–4.60) < 0.001 2.33(1.59–3.43) < 0.001 2.32(1.58–3.42) < 0.001
≥ 27.12-≥ 0.56 325/1481(21.94) 4.02(3.11–5.21) < 0.001 2.51(1.92–3.29) < 0.001 2.27(1.70–3.03) < 0.001
BMI (kg/m2)- WHR
< 27.12- < 0.83 46/1464(3.14) Reference – Reference – Reference –
≥ 27.12- < 0.83 85/703(12.09) 3.25(2.25–4.67) < 0.001 2.31(1.59–3.34) < 0.001 2.11(1.44–3.08) < 0.001
< 27.12-≥ 0.83 77/621(12.40) 3.32(2.29–4.81) < 0.001 2.55(1.75–3.71) < 0.001 2.54(1.75–3.70) < 0.001
≥ 27.12-≥ 0.83 282/1241(22.72) 5.67(4.10–7.86) < 0.001 3.33(2.37–4.67) < 0.001 2.99(2.10–4.25) < 0.001
BMI (kg/m2)- HC
< 27.12- < 103 92/1627 (5.65) Reference – Reference – Reference –
≥ 27.12- < 103 37/214 (17.29) 2.39(1.63–3.52) < 0.001 1.68(1.13–2.48) 0.009 1.56(1.05–2.31) 0.026
< 27.12-≥ 103 31/458 (6.77) 1.09(0.72–1.64) 0.669 1.07(0.71–1.61) 0.721 1.02(0.67–1.53) 0.923
≥ 27.12-≥ 103 330/1730 (19.08) 2.66(2.10–3.38) < 0.001 1.79(1.40–2.30) < 0.001 1.58(1.20–2.07) 0.001
aAdjusted for age (in time-scale manner), education level, family history of type 2 diabetes, systolic blood pressure, fasting plasma glucose, and triglyceride to
high-density lipoprotein cholesterol ratio
bAdjusted for model 1 variables and wrist circumference
HR hazard ratio, CI confidence interval, BMI body mass index, WC waist circumference, WHtR waist to height ratio, WHR waist to hip ratio, HC hip circumference
Table 6 Sex-specific Prediction Accuracy of the Combined High
Anthropometric Indices for Incident Type 2 Diabetes, TLGS study
Sensitivity (%) Specificity (%) PPV (%)
Men (N = 2419)
BMI≥ 25.56- WC≥ 89 68.1% 59.4% 18.4%
BMI≥ 25.56- WHtR ≥ 0.52 68.1% 59.8% 18.5%
BMI≥ 25.56- WHR≥ 0.91 62.4% 64.8% 19.3%
BMI≥ 25.56- HC≥ 96 68.4% 58.2% 18.0%
Women (N = 3319)
BMI≥ 27.12- WC≥ 87 65.9% 65.2% 20.8%
BMI≥ 27.12- WHtR ≥ 0.56 66.3% 67.3% 21.9%
BMI≥ 27.12- WHR≥ 0.83 57.6% 72.9% 22.7%
BMI≥ 27.12- HC≥ 103 67.3% 60.4% 19.1%
BMI body mass index, WC waist circumference, WHtR waist to height ratio,
WHR waist to hip ratio, HC hip circumference, PPV positive predictive value
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obesity indices no matter which index is high. Further-
more, it seems that combined high values of general and
central obesity indices increase the specificity for the price
of reduced sensitivity and PPV in predicting incident T2D.
Considering limitations, our results cannot be ex-
trapolated to elder populations since participants of
our study are adults, 20–60 years of age. In addition,
excluding participants affected by conditions such as
autoimmune diseases and acute or chronic infections
which are known to impair glucose tolerance was not
possible at baseline examination; however, those suf-
fering from cancer, end-stage renal disease or cirrho-
sis were excluded. Likewise, we could not collect data
regarding the use of estroprogestins in our partici-
pants, nevertheless, use of other drugs that have the
potential to affect glucose impairment was carefully
observed. Also, as shown in Table 1, respondent par-
ticipants in our study generally had significantly
higher levels of risk factors which might lead to over-
estimation of T2D incidence. These statistically
significant differences might be attributed to large
study sample size and they are not significant from
the clinical point of view (e.g. mean of WHtR = 0.51
and 0.50 in respondents and non-respondents men,
respectively). Moreover, almost all of the risk factors
were adjusted in the multivariable models. Finally, un-
fortunately, HbA1C was not measured in TLGS par-
ticipants; hence, we could not use HbA1c as a
criterion for defining diabetic patients.
As for the strengths, our study included a large repre-
sentative sample of Iranian adults in a sex-stratified
population with reliable follow-up data. We had a rea-
sonable number of events which allowed us to evaluate
the long-term effects of anthropometric indices on T2D
incidence. Also, we used both FPG and 2 h-PCPG as in-
dicators of diabetes status both at baseline and follow-up
examinations allowing us to have an accurate estimation
of incident T2D.
Conclusions
In conclusion, all anthropometric variables showed
significant association with incident T2D considering a
wide set of covariates including wrist circumferencein
both sexes, except hip circumference in men. We
showed that among all the obesity indices, in both sexes,
WHtR performed the best while HC had the lowest pre-
diction power. Fixing sensitivity at about 75%, not to
miss more than 25% of at-risk individuals for develop-
ment of T2D in long term, our derived cut-points for
BMI, WC, WHtR, WHR, and HC in the Iranian popula-
tion were 25.56 kg/m2, 89 cm, 0.52, 0.91, and 96 cm in
men and 27.12 kg/m2, 87 cm, 0.56, 0.83, and 103 in
women, respectively. Our derived cut-points for BMI
and WHtR in both sexes, and WC in women are higher
than the traditionally used cut-points, leading to a con-
siderable reduction in false positive rates. Therefore, they
might perform better if applied in the Iranian popula-
tion. Further studies in other Iranian populations are re-
quired to check the external validity of our proposed
cut-points in predicting development of T2D.
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